相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body Dementias
Erica Howard et al.
NEUROLOGY (2021)
Integrated 18F-T807 Tau PET, Structural MRI, and Plasma Tau in Tauopathy Neurodegenerative Disorders
Cheng-Hsuan Li et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
CSF or serum neurofilament light added to α-Synuclein panel discriminates Parkinson's from controls
Linda P. Oosterveld et al.
MOVEMENT DISORDERS (2020)
Magnetic Resonance Imaging and Neurofilament Light in the Differentiation of Parkinsonism
Derek B. Archer et al.
MOVEMENT DISORDERS (2020)
Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series
H. Geut et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Cerebrospinal Fluid and Plasma Biomarkers in Neurodegenerative Diseases
Yusuke Seino et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Serum NFL discriminates Parkinson disease from atypical parkinsonisms
Taina M. Marques et al.
NEUROLOGY (2019)
Neurofilament light chain as a biomarker in neurological disorders
Lorenzo Gaetani et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
CSF and blood biomarkers for Parkinson's disease
Lucilla Parnetti et al.
LANCET NEUROLOGY (2019)
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
Suzanne E. Schindler et al.
NEUROLOGY (2019)
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Akinori Nakamura et al.
NATURE (2018)
Plasma Biomarkers Differentiate Parkinson's Disease From Atypical Parkinsonism Syndromes
Chin-Hsien Lin et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis
Giulio Disanto et al.
ANNALS OF NEUROLOGY (2017)
Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia
Stephen N. Gomperts et al.
NEUROLOGY (2013)
Cerebrospinal Fluid Tau and Phosphorylated Tau Protein are Elevated in Corticobasal Syndrome
M. B. Aerts et al.
MOVEMENT DISORDERS (2011)
Differential Pattern of Brain-Specific CSF Proteins Tau and Amyloid-Beta in Parkinsonian Syndromes
Sigurd D. Suessmuth et al.
MOVEMENT DISORDERS (2010)
Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2008)
Second consensus statement on the diagnosis of multiple system atrophy
S. Gilman et al.
NEUROLOGY (2008)
Accuracy of clinical diagnosis of progressive supranuclear palsy
Y Osaki et al.
MOVEMENT DISORDERS (2004)
Neurodegenerative tauopathies
VMY Lee et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
分享论文
